{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:17Z","timestamp":1787013917896,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/bjd.12505","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T04:20:44Z","timestamp":1373948444000},"page":"901-909","source":"Crossref","is-referenced-by-count":97,"title":["The European treatment of severe atopic eczema in children taskforce (TREAT) survey"],"prefix":"10.1093","volume":"169","author":[{"given":"L.E.","family":"Proudfoot","sequence":"first","affiliation":[{"name":"St John's Institute of Dermatology; Guy's and St Thomas' NHS Foundation Trust; London SE1 9RT U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Powell","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology; Guy's and St Thomas' NHS Foundation Trust; London SE1 9RT U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ayis","sequence":"additional","affiliation":[{"name":"Division of Health and Social Care Research; Guy's and St Thomas' NHS Foundation Trust; London SE1 9RT U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barbarot","sequence":"additional","affiliation":[{"name":"Department of Dermatology; CHU H\u00f4tel-Dieu; 44035 Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Baselga Torres","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit; Department of Dermatology; Hospital de la Santa Creu i Sant Pau; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deleuran","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"F\u00f6lster-Holst","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital Schleswig-Holstein; Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gelmetti","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation; University of Milan and Fondazione IRCCS Ca' Granda; Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hern\u00e1ndez-Martin","sequence":"additional","affiliation":[{"name":"Hospital Infantil Ni\u00f1o Jes\u00fas; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Middelkamp-Hup","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Academic Medical Center; Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Oranje","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Maasstadziekenhuis; Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Logan","sequence":"additional","affiliation":[{"name":"Division of Asthma, Allergy and Lung Biology; Department of Paediatric Allergy; King's College London; London U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Division of Asthma, Allergy and Lung Biology; Department of Paediatric Allergy; King's College London; London U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Patrizi","sequence":"additional","affiliation":[{"name":"Dermatology, Department of Specialised, Experimental and Diagnostic Medicine; University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rovatti","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation; University of Milan and Fondazione IRCCS Ca' Granda; Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Schofield","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Royal Infirmary of Edinburgh; Edinburgh U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Spuls","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Academic Medical Center; Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Institute of Clinical Research in Malm\u00f6; Sk\u00e5ne University Hospital; Lund University; Malm\u00f6 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-F.","family":"Wahlgren","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Department of Medicine Solna; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Healthcare; University of Dresden; Dresden Germany"},{"name":"Department of Social and Occupational Medicine; University of Dresden; Dresden Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Flohr","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology; Guy's and St Thomas' NHS Foundation Trust; London SE1 9RT U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"in collaboration with the European Dermato-Epidemiology Network (EDEN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"10.1111\/bjd.12505-BIB0001|bjd12505-cit-0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/bjd.12505-BIB0002|bjd12505-cit-0002","doi-asserted-by":"crossref","first-page":"e4770","DOI":"10.1136\/bmj.e4770","article-title":"Management of difficult and severe eczema in childhood","volume":"345","author":"McAleer","year":"2012","journal-title":"BMJ"},{"key":"10.1111\/bjd.12505-BIB0003|bjd12505-cit-0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12505-BIB0004|bjd12505-cit-0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","author":"Stalder","year":"1993","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12505-BIB0005|bjd12505-cit-0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000193997","article-title":"Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study","volume":"218","author":"Vourc'h-Jourdain","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12505-BIB0006|bjd12505-cit-0006","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2133.2000.03300.x","article-title":"The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading","volume":"142","author":"Emerson","year":"2000","journal-title":"Br J Dermatol"},{"issue":"Suppl. 48","key":"10.1111\/bjd.12505-BIB0007|bjd12505-cit-0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.1996.tb00706.x","article-title":"Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis","volume":"135","author":"Berth-Jones","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0008|bjd12505-cit-0008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective","volume":"140","author":"Charman","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12505-BIB0009|bjd12505-cit-0009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2133.2003.05157.x","article-title":"The Children's Dermatology Life Quality Index: validation of the cartoon version","volume":"148","author":"Holme","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0010|bjd12505-cit-0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2133.2001.03960.x","article-title":"The infants' dermatitis quality of life index","volume":"144","author":"Lewis-Jones","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0011|bjd12505-cit-0011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2133.1998.02034.x","article-title":"The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire","volume":"138","author":"Lawson","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0012|bjd12505-cit-0012","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12505-BIB0013|bjd12505-cit-0013","first-page":"139","article-title":"High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis","volume":"4","author":"Bemanian","year":"2005","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1111\/bjd.12505-BIB0014|bjd12505-cit-0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0015|bjd12505-cit-0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.289.6446.651","article-title":"Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomized controlled trial","volume":"289","author":"Heddle","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/bjd.12505-BIB0016|bjd12505-cit-0016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4168\/aair.2011.3.2.89","article-title":"Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis","volume":"3","author":"Jee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1111\/bjd.12505-BIB0017|bjd12505-cit-0017","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0011-393X(95)85143-7","article-title":"A randomized, double-blind, placebo-controlled, crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis","volume":"56","author":"La Rosaa","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1111\/bjd.12505-BIB0018|bjd12505-cit-0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1399-3038.2001.012003154.x","article-title":"Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study","volume":"12","author":"Pei","year":"2001","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/bjd.12505-BIB0019|bjd12505-cit-0019","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0190-9622(96)90281-9","article-title":"Cyclosporine in severe childhood atopic dermatitis: a multicenter study","volume":"34","author":"Berth-Jones","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12505-BIB0020|bjd12505-cit-0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200969030-00005","article-title":"Systemic therapy of atopic dermatitis in children","volume":"69","author":"Ricci","year":"2009","journal-title":"Drugs"},{"key":"10.1111\/bjd.12505-BIB0021|bjd12505-cit-0021","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.celrep.2012.10.013","article-title":"Hypomethylation of the IL17RC promoter associates with age-related macular degeneration","volume":"2","author":"Wei","year":"2012","journal-title":"Cell Rep"},{"key":"10.1111\/bjd.12505-BIB0022|bjd12505-cit-0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1525-1470.2007.00549.x","article-title":"Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema","volume":"24","author":"Pedreira","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.12505-BIB0023|bjd12505-cit-0023","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1542\/peds.2007-2232","article-title":"Management of atopic dermatitis in the pediatric population","volume":"122","author":"Krakowski","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.12505-BIB0024|bjd12505-cit-0024","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12505-BIB0025|bjd12505-cit-0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2001.012004216.x","article-title":"Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects","volume":"12","author":"Bunikowski","year":"2001","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/bjd.12505-BIB0026|bjd12505-cit-0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00431-012-1893-3","article-title":"Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt","volume":"172","author":"El-Khalawany","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1111\/bjd.12505-BIB0027|bjd12505-cit-0027","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2133.2002.04989.x","article-title":"Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial","volume":"147","author":"Berth-Jones","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0028|bjd12505-cit-0028","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(06)68340-2","article-title":"Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial","volume":"367","author":"Meggitt","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/bjd.12505-BIB0029|bjd12505-cit-0029","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09546630802512646","article-title":"Efficacy and tolerability at 3 and 6\u00a0months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults","volume":"20","author":"Hon","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12505-BIB0030|bjd12505-cit-0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2012.07.001","article-title":"Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring","volume":"68","author":"Caufield","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12505-BIB0031|bjd12505-cit-0031","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2011.03.024","article-title":"A randomized trial of methotrexate versus azathioprine for severe atopic eczema","volume":"128","author":"Schram","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12505-BIB0032|bjd12505-cit-0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-0960.2008.00451_1.x","article-title":"Systemic therapy of paediatric atopic dermatitis: an update","volume":"49","author":"Borchard","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0033|bjd12505-cit-0033","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2133.2007.07947.x","article-title":"Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients","volume":"157","author":"Heller","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12505-BIB0034|bjd12505-cit-0034","first-page":"CD003871","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema","volume":"3","author":"Birnie","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.12505-BIB0035|bjd12505-cit-0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bmj.332.7547.933","article-title":"Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial","volume":"332","author":"Staab","year":"2006","journal-title":"BMJ"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12505","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12505\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:06:10Z","timestamp":1676365570000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/4\/901\/6615119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12505","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}